Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Cancers”

775 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 775 results

Testing effectiveness (Phase 2)UnknownNCT04033302
What this trial is testing

Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaAcute Myeloid Leukemia+1 more
Shenzhen Geno-Immune Medical Institute 30
Testing effectiveness (Phase 2)Study completedNCT00603954
What this trial is testing

Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings

Who this might be right for
Hematological Malignancies
University of Liege 107
Not applicableStudy completedNCT05236296
What this trial is testing

Emotion and Symptom-focused Engagement for Caregivers (EASE-CG) Pilot Study

Who this might be right for
Leukemia, Acute
University Health Network, Toronto 40
Early research (Phase 1)Looking for participantsNCT06225856
What this trial is testing

An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Advanced Solid TumorHematological Malignancy
Shanghai Yuyao Biotech Co., Ltd. 96
Not applicableLooking for participantsNCT07147621
What this trial is testing

Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaHodgkin's LymphomaNon-Hodgkin's Lymphoma
University Hospital, Angers 120
Not applicableStudy completedNCT05549232
What this trial is testing

Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital

Who this might be right for
Hematologic NeoplasmsBurns
Hemanext 22
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Testing effectiveness (Phase 2)Ended earlyNCT03214666
What this trial is testing

GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies

Who this might be right for
High-risk Myelodysplastic SyndromesAcute Myelogenous LeukemiaSystemic Mastocytosis+1 more
GT Biopharma, Inc. 12
Not applicableNot Yet RecruitingNCT07525024
What this trial is testing

KSD-101 in Patients With EBV-associated Hematological Malignancies

Who this might be right for
EBV Associated Lymphoid Neoplasms
Ruijin Hospital 80
Early research (Phase 1)Study completedNCT02143635
What this trial is testing

Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt

Who this might be right for
Advanced Solid and Hematological TP53wt Tumors
Novartis Pharmaceuticals 208
Early research (Phase 1)Study completedNCT00904787
What this trial is testing

Study of ENMD-2076 in Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Relapsed or Refractory Hematological Malignancies
CASI Pharmaceuticals, Inc. 27
Testing effectiveness (Phase 2)UnknownNCT02828878
What this trial is testing

Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation

Who this might be right for
Hematological Malignancies
Cellect Biotechnology 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06180499
What this trial is testing

Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion

Who this might be right for
Hematological MalignanciesRegulatory T Cell DepletionRelapse
Assistance Publique - Hôpitaux de Paris 27
Early research (Phase 1)Looking for participantsNCT06950034
What this trial is testing

STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia (CMML)Chronic Myelomonocytic Leukemia-1+9 more
Solu Therapeutics, Inc 105
Testing effectiveness (Phase 2)Study completedNCT00843947
What this trial is testing

Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan

Who this might be right for
Hematologic Malignancies
University of California, Davis 8
Testing effectiveness (Phase 2)UnknownNCT00524784
What this trial is testing

Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD

Who this might be right for
Graft Versus Host DiseaseHematological Malignancies
Hadassah Medical Organization 12
Testing effectiveness (Phase 2)Study completedNCT01517035
What this trial is testing

Improving Blood Stem Cell Collection and Transplant Procedures

Who this might be right for
Myelodysplastic Syndrome (MDS)Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 43
Large-scale testing (Phase 3)Active Not RecruitingNCT04547049
What this trial is testing

A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

Who this might be right for
LeukemiaMDS
First Affiliated Hospital of Zhejiang University 232
Early research (Phase 1)Active Not RecruitingNCT06325748
What this trial is testing

SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

Who this might be right for
AML/MDSCD33 Expressing Hematological MalignanciesFLT3 Expressing Hematological Malignancies
Senti Biosciences 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175415
What this trial is testing

HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory+2 more
Princess Maxima Center for Pediatric Oncology
Load More Results
42